Skip to content

Clinical trials

Observational Breast Neoplasms trials in India

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Breast Neoplasms Phase: Observational Country / region: India Clear all

16 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20081
20111
20131
20151
20174
20181
20191
20214
20241
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed9
Unknown status4
Recruiting2
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Tata Memorial Centre3
Pfizer2
AstraZeneca1
Banaras Hindu University1
Basavatarakam Indo American Cancer Hospital & Research Institute1
Hoffmann-La Roche1
Jules Bordet Institute1
Niramai Health Analytix Private Limited1
Novartis Pharmaceuticals1
POC Medical Systems, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Breast Neoplasms16
Endometrial Neoplasms1
Neoplasms1
Ovarian Neoplasms1
Radiation Injuries1
Uterine Cervical Neoplasms1

Trials

Showing 1 to 16 of 16. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.